Re:Clues to Covid-19 coronavirus’s vulnerability emerge from...
by Symmetry on Saturday April 04, 2020 @08:33AM
(#22777880)
It's too large and complex to do now but I bet we'll be able to do that sort of thing by 2040.
[ Parent
| on HN ]
Re:Clues to Covid-19 coronavirus’s vulnerability emerge from...
by koheripbal on Saturday April 04, 2020 @11:56AM
(#22779010)
The reason it's not researched much is because giving someone an antibody will not confer immunity - it will only treat the immediate virus.
It has value, but there are usually better treatments available that more broadly fight a variety of viruses and don't need to be so specifically customized as an antibody.
Re:Clues to Covid-19 coronavirus’s vulnerability emerge from...
by dukoid on Saturday April 04, 2020 @01:16PM
(#22779686)
I suppose testing would be easier for a cure (compared to a vaccine)? Given that only the "adapter" needs to be specialized, I was wondering why there don't seem to be any approaches based on antibody mass-production....
Re:Clues to Covid-19 coronavirus’s vulnerability emerge from...
by woofie11 on Saturday April 04, 2020 @10:05AM
(#22778282)
I have a friend who runs a company which genetically engineers cells to make chemicals for a living. This doesn't seem like 2040-era science fiction.
Indeed, I'm not sure it's out-of-scope for 2020-era technology.
Re:Clues to Covid-19 coronavirus’s vulnerability emerge from...
by nojvek on Saturday April 04, 2020 @03:32PM
(#22780818)
What is the said company ?
Re:Clues to Covid-19 coronavirus’s vulnerability emerge from...
by woofie11 on Sunday April 05, 2020 @10:22PM
(#22790405)
Ginko Bioworks.
Apparently it's grown quite a bit since I've spoken to my friend. When we last checked in, it was a little startup. Now, it's a $2.4 billion dollar operation. I guess my friend is probably worth a few hundred million right now.